The ASGCT Patient Education Program was initiated in January 2018 with the goal of making accurate, reliable, and accessible information about gene and cell therapies available to patients and the public. We encourage you to share these resources with colleagues, friends, and family interested in learning more.

Additional topics include:

• Gene Therapy 101
• COVID-19 Vaccines
• Disease Treatments
• Clinical Trials
• Patient Journey

Visit https://patienteducation.asgct.org/ often as we continue to add topics!

When individuals join ASGCT, they contribute to a unique multidisciplinary group. ASGCT provides individuals with an opportunity to network, present research at the ASGCT Annual Meeting, and to promote education about gene and cell therapy advances and challenges.

Choose which membership is right for you:

• Member—individuals who have demonstrated a professional interest in gene therapy, cell therapy, or manufacturing technologies for gene and cell delivery are eligible.
   
• Associate Member—postdoctoral fellows, undergraduate or graduate students, laboratory assistants, technicians, and other laboratory staff in gene and cell therapy are eligible.
   
• Transitional Member-- Individuals participating in gene therapy, cell therapy, or manufacturing technologies for gene and cell delivery, as evidenced by work in the field who are in a period of career transition are eligible for a maximum of two years at a reduced rate.

Learn more

Molecular Therapy is the leading research journal in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2019 impact factor is 8.986.

The Molecular Therapy family of journals includes:

• Methods & Clinical Development
• Nucleic Acids
• Oncolytics

ASGCT members receive an online subscription with full access to content within the Molecular Therapy Family of Journals. Full and transitional members receive publication discounts of $700 for open access articles or $52 per page.

Each seminar consists of three mini sessions with materials sent to registered attendees in advance, utilizing a flipped classroom approach to allow more time for presenters to discuss application and answer questions.

The live seminars are free for all attendees and accessible on-demand for ASGCT members.

Upcoming seminar topics:

• June 11: Academic Writing Dos and Don’ts
• July: "How To" with AAV Vectors
• August: Grant Writing
• September: Top 10 Areas of Study in Gene and Cell Therapy
• October: "How To" with Cas 9 and CRISPR

Learn more